









|
| @ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹ |
<< Šw‰ïނ֖߂é
<< ‘O‚̃y[ƒW‚Ö–ß‚é
‘æ84‰ñŠwpW‰ïi•½¬4”N10ŒŽ25“új
yˆê”ʉ‰‘èz
”S–Œ‰º‹ØŽî‚ɑ΂·‚éGn-RH agonist‚ÌŽg—pã‚Ì–â‘è“_
‚–Ø@Í”ü, ‚“c@áÁˆê, ÎŒ´@—, ŠÖ@”Ž”V, –؉º@Ÿ”V
é‹Êˆã‰È‘åŠw‘‡ˆã—ÃZƒ“ƒ^[
“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 30(1)
118-118, 1993
|